Heritability of Low ER Staining/HER2-Breast Tumors: Are We Missing an Opportunity for Germline Testing?

In 2010, the genetic testing criteria was changed to allow women diagnosed ≤ 60 years old with triple negative breast cancer (TNBC) to undergo germline testing. In the same year, estrogen receptor (ER) positivity was defined as having ≥1% ER staining cells. While tumors with 1–10% ER staining cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovejoy, Leann A., Turner, Clesson E., Wells, Justin M., Shriver, Craig D., Ellsworth, Rachel E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763582/
https://www.ncbi.nlm.nih.gov/pubmed/33302456
http://dx.doi.org/10.3390/genes11121469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763582/
https://www.ncbi.nlm.nih.gov/pubmed/33302456
http://dx.doi.org/10.3390/genes11121469

Ejemplares similares